Extrusion Manufacturer Johnson Plastic Group
Material science and manufacturing technologies
specialist Tekni-Plex Healthcare has acquired precision extrusion manufacturer
Johnson Plastic Group (JPG) as part of a strategy to
expand the company’s patient care solutions platform.
Located in Mexicali, Mexico, JPG provides complete
extrusion solutions into a variety of medical device applications for
interventional and therapeutic procedures.
The acquisition expands Tekni-Plex
Healthcare’s medical device capabilities and broadens the division’s global
footprint. The transaction also brings the company closer to its key customer
base in Mexico and the Baja region, as well as leveraging JPG’s expertise across
Tekno-Ples Healthcare’s entire global customer base and healthcare end markets.
Chris Qualters, CEO of Tekni-Plex
Healthcare noted: “The addition of JPG continues to build upon our innovative
patient care solutions platform centered on material science and process
Medtech Opens Manufacturing Facility At Rohisa Industrial Estate, Ahmedabad For
Healthium Medtech has announced the
launch of its latest manufacturing facility in Ahmedabad. The facility owned by
Uteshiya Medicare, is located at the Rohisa Industrial Estate, and has been
licenced by Healthium Medtech to exclusively manufacture its wide range of
arthroscopy products marketed under the brand ‘Sironix’.
The CDSCO certified facility is
spread across 70,000 sq ft. The facility was inaugurated by Gujarat’s minister
for rural housing & development, Arjunsinh Chauhan.
The company is India’s largest
independent medical devices company and second-largest company overall, in the
surgical consumables market, the largest non-captive surgical needles
manufacturer globally, by volume and the third-largest company overall in the
urology collection devices market in the UK as of fiscal 2021. Ending March
2021, one in five surgeries conducted globally, uses a Healthium product.
It currently operates across eight
integrated and scaled manufacturing facilities, several of which have global
accreditations and registrations including US FDA, CE, ISO and TGA. Of these,
seven are located in India spread across Karnataka, Uttar Pradesh, Andhra
Pradesh, Tamil Nadu, Maharashtra and now Gujarat, and one in China. The company
was the 1st Class III medical device company in India to receive a US FDA
registration for one of its facilities.
Anish Bafna, chief executive
officer and managing director, Healthium Medtech said, “Arthroscopy is one of
the fastest growing orthopaedic procedures in India, accounting for 15-17% of
the overall procedures. We have created a patented portfolio of arthroscopy
products at Healthium and we are very happy to have found in Uteshiya Medicare,
a partner that offers the right environment to boost the manufacturing of our
arthroscopy portfolio, while ensuring seamless delivery.”
Jignesh Uteshiya, director Uteshiya
Medicare, said, “We are excited to have partnered with Healthium Medtech and
look forward to manufacturing their patented arthroscopy portfolio in a
completely green facility built using recycled materials, with builtin energy
efficient systems, rainwater harvesting and onsite renewable energy generation.
We are also optimizing and customizing operations for maximum efficiency with
stringent quality control processes in place. Our most important capital is the
perfect synergy of a green environment, competent talent and the effective use
of global know-how through practical application.”
Arthroscopy products are used to
help treat various knee and shoulder conditions such as anterior cruciate
ligament reconstruction, posterior cruciate ligament injuries and other ligament
reconstruction and repair and meniscal repair. As per Frost & Sullivan report,
the Indian arthroscopy devices market was valued at US$ 18.9 million in 2020,
and estimated to reach US$ 47.1 million by 2025, implying a CAGR (2021-2025) of
Arthroscopy accounts for 15-17% of
total orthopaedic procedures carried out in India, and is one of the fastest
growing orthopaedic procedures. The volume of arthroscopy procedures conducted,
is likely to triple in the next 5-6 years. Key drivers for growth of procedures
include a growing base of arthroscopy centres and practicing specialists.